Vasopharm
ID: 5290761A company developing therapeutics for acute inflammatory central nervous system conditions
5
Funding Rounds
$35.0m
Money raised
Recent Funding Rounds
Overview
A company developing therapeutics for acute inflammatory central nervous system conditions
- Website:
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ul**** Wa**** | - | - | - |
| Ha**** Sc***** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Vasopharm has raised a total of $24.3m in funding over 5 rounds.
Key Insights:
- Vasopharm Series F round: $6.5m
- Vasopharm Series D round: $6m
- Vasopharm Series B round: $11.8m
- vasopharm GmbH funding round, July 2019: $10.7m
Industries
Vasopharm is active in the following industries: